Pharmaceutical companies are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. However, accessing, analyzing, and utilizing complex RWD is frequently challenging. Datma's Federated Biomarker Explorer provides a cutting-edge solution by o